Literature DB >> 32101158

Antimicrobial resistance in Shiga toxin-producing Escherichia coli other than serotype O157 : H7 in England, 2014-2016.

Amy Gentle1, Martin R Day1, Katie L Hopkins1, Gauri Godbole1, Claire Jenkins1.   

Abstract

Introduction. Despite many ongoing surveillance projects and the recent focus on the veterinary and clinical 'One Health' aspects of antimicrobial resistance (AMR), evidence of the extent of any public health risk posed by animal reservoirs with respect to the transmission of resistant strains of Escherichia coli to humans remains varied and contentious. In the UK, the main zoonotic reservoir for the foodborne pathogen Shiga toxin-producing E. coli (STEC) is cattle and sheep. In this study, we adopt an alternative approach to the risk assessment of transmission of AMR E. coli from animals to humans, involving monitoring AMR in isolates of STEC, an established zoonotic, foodborne pathogen, from human cases of gastrointestinal disease.Aim. The aim of this study was to determine the genome-derived AMR profiles for STEC from human cases to assess the risk of transmission of multidrug-resistant STEC from ruminants to humans.Methodology. STEC belonging to 10 different clonal complexes (CCs) (n=457) isolated from human faecal specimens were sequenced and genome-derived AMR profiles were determined. Phenotypic susceptibility testing was undertaken on all isolates (n=100) predicted to be resistant to at least one class of antimicrobial.Results. Of the 457 isolates, 332 (72.7 %) lacked identifiable resistance genes and were predicted to be fully susceptible to 11 classes of antimicrobials; 125/332 (27.3 %) carried 1 or more resistance genes, of which 83/125 (66.4 %) were resistant to 3 or more classes of antibiotic. The percentage of isolates harbouring AMR determinants varied between CCs, from 4% in CC25 to 100% in CC504. Forty-six different AMR genes were detected, which conferred resistance to eight different antibiotic classes. Resistance to ampicillin, streptomycin, tetracyclines and sulphonamides was most commonly detected. Four isolates were identified as extended-spectrum β-lactamase producers. An overall concordance of 97.7 % (n=1075/1100) was demonstrated between the phenotypic and genotypic methods.Conclusion. This analysis provided an indirect assessment of the risk of transmission of AMR gastrointestinal pathogens from animals to humans, and revealed a subset of human isolates of the zoonotic pathogen STEC were resistant to the antimicrobials used in animal husbandry. However, this proportion has not increased over the last three decades, and thismay provide evidence that guidancepromoting responsible practice has been effective.

Entities:  

Keywords:  Shiga toxin-producing Escherichia coli; antimicrobial resistance; one health

Mesh:

Substances:

Year:  2020        PMID: 32101158     DOI: 10.1099/jmm.0.001146

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Whole-genome sequencing analysis of Shiga toxin-producing Escherichia coli O22:H8 isolated from cattle prediction pathogenesis and colonization factors and position in STEC universe phylogeny.

Authors:  Wanderson Marques Da Silva; Mariano Larzabal; Flavia Figueira Aburjaile; Nahuel Riviere; Luisina Martorelli; James Bono; Ariel Amadio; Angel Cataldi
Journal:  J Microbiol       Date:  2022-06-22       Impact factor: 3.422

2.  Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England.

Authors:  Claire Jenkins; Lisa Byrne; Bhavita Vishram; Clare Sawyer; Sooria Balasegaram; Laura Ahyow; Sally Johnson
Journal:  J Med Microbiol       Date:  2020-07       Impact factor: 2.472

3.  Epidemiology and genomic analysis of Shiga toxin-producing Escherichia coli clonal complex 165 in the UK.

Authors:  Ella V Rodwell; Bhavita Vishram; Robert Smith; Lynda Browning; Alison Smith-Palmer; Lesley Allison; Anne Holmes; Gauri Godbole; Noel McCarthy; Timothy J Dallman; Claire Jenkins
Journal:  J Med Microbiol       Date:  2021-12       Impact factor: 2.472

4.  Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020.

Authors:  Silje N Ramstad; Lin T Brandal; Arne M Taxt; Yngvild Wasteson; Jørgen V Bjørnholt; Umaer Naseer
Journal:  J Med Microbiol       Date:  2021-12       Impact factor: 2.472

5.  The Importance of Shiga Toxin-Producing Escherichia coli O145:NM[H28]/H28 Infections in Argentina, 1998-2020.

Authors:  Claudia Carolina Carbonari; Elizabeth Sandra Miliwebsky; Gisela Zolezzi; Natalia Lorena Deza; Nahuel Fittipaldi; Eduardo Manfredi; Ariela Baschkier; Beatriz Alejandra D'Astek; Roberto Gustavo Melano; Carla Schesi; Marta Rivas; Isabel Chinen
Journal:  Microorganisms       Date:  2022-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.